- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT01071668
Onset of Labor and Metabolomics (GEM-2) (GEM-2)
Feasibility Study to Develop the Analysis of the Metabolome During the Onset of Labor During Pregnancy
Premature birth is a public health problem and its incidence has recently increased in all developed countries. In Canada, it represented 6.4% of births in 1981 and 7.6% in 2000. In the last decade, the survival rate of premature infants has increased considerably, but neurological vulnerability has not changed. Premature births are the cause of approximately 28% of neonatal mortality in the world and is the major cause of perinatal mortality and morbidity in developed countries.
Approximately 75-80% of preterm births are spontaneous preterm birth. This type of premature birth included the preterm labor and premature rupture of membranes before term. The contractile activity represents one of the fundamental properties of the uterus during pregnancy and childbirth. The abnormalities associated with uterine contractions are the cause of pathological conditions with important consequences for the mother and fetus.
Metabolomics involves a new technology to investigate small molecules that characterize biochemical pathways of interest. The change in concentration levels of these molecules in various biological samples such as urine and blood in the presence of a disease or a patient can be particularly useful for identifying new biomarkers.
The hypothesis of this study is that gestational metabolomes detected in maternal fluids differ according to pathological situations and lead to the initiation of spontaneous labor. The whole research program has two complementary objectives in order to expect a decrease of prematurity: a) better understanding of all the physiological mechanisms leading to prematurity and b) better identification of patients at high risk for a better management of these women.
Descripción general del estudio
Estado
Condiciones
Descripción detallada
Metabolomics involves a new technology using the methods of separation and detection complex to investigate a set of small molecules that characterize biochemical pathways of interest. The change in concentration levels of these molecules in various biological samples such as urine and blood in the presence of a disease or a patient can detect metabolic fingerprints that can be particularly useful for identifying new biomarkers. These will thereafter be quantified and validated by metabolic profiling. To our knowledge, there are few studies on metabolomics and pregnancy.
Methods:
The studied population will be pregnant women between 20-30 weeks of gestation without any obstetrical complications.
Vaginal secretions, blood and urine samples will be taken:
- After inclusion in the project
- At hospital admission for delivery
- During labor
Blood and urine sample will also be taken:
- 48 hours after delivery
- 6-8 weeks after delivery
Tipo de estudio
Inscripción (Anticipado)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Quebec
-
Sherbrooke, Quebec, Canadá, J1H 5N4
- Centre Hospitalier de l'Université de Sherbrooke
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- Women with single pregnancy
- Adults (> 18 years old)
Exclusion Criteria:
- Women with a severe congenital fetal malformation
- Fetal death
- Preexisting hypertension (ie before 20 weeks of gestation)
- Anti-phospholipid syndrome
- Lupus,
- Nephropathy, etc.
- Viral infections (HIV or hepatitis)
- Women who want an elective Caesarean section are excluded
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
---|
GEM-2 Cohort
Women who have a low risk pregnancy before onset of labor.
Patients included in the study who will be hospitalized with spontaneous labor at term with intact membranes or preterm labor will be included in the study group.
Patients with premature rupture of membranes or induction of labor will be analyzed separately.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Periodo de tiempo |
---|---|
comparison between the metabolic patterns of women before and during labor
Periodo de tiempo: one and half year
|
one and half year
|
Medidas de resultado secundarias
Medida de resultado |
Periodo de tiempo |
---|---|
The study also looks at the comparison of metabolic patterns in late pregnancy and postpartum.
Periodo de tiempo: one and half year
|
one and half year
|
The project will characterize the metabolome in different fluids collected
Periodo de tiempo: one and half year
|
one and half year
|
The study will compare the metabolome of women with spontaneous onset of labor with that of women with premature rupture of membranes or induction of labor
Periodo de tiempo: one and half year
|
one and half year
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Anticipado)
Finalización del estudio (Anticipado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- 09-041
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .